Importance of TNF-α and leptin in obesity and insulin resistance: A hypothesis on the impact of physical exercise

Exercise Immunology Review

Volumn , Issue 4, 1998, Pages 77-94

  Halle, Martin ^a   Berg, Aloys ^a   Northoff, Hinnak ^b   Keul, Joseph ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ATHLETE; CARDIOVASCULAR RISK; DIET; ENZYME ACTIVITY; EXERCISE; FIBRINOLYSIS; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; METABOLIC REGULATION; MUSCLE CELL; NONHUMAN; OBESITY; REVIEW; THERMOGENESIS; WEIGHT REDUCTION;

ANIMALS; ARTERIOSCLEROSIS; CORONARY DISEASE; DIET; EXERCISE; HUMANS; INSULIN RESISTANCE; LEPTIN; OBESITY; PROTEINS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 0031862996     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Alessi, M.C., Peiretti, P. Morange, M. Henry, G. Nalbone, and I. Juhan-Vague. Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997.
2. Argiles, J.M., Lopez-Soriano, S. Busquets, and F.J. Lopez-Soriano. Journey from cachexia to obesity by TNF. FASEB J. 11:743-751, 1997.
3. Bemelmans, M.H., J. van Tits, and W.A. Buurman. Tumor necrosis factor: Function, release and clearance [Review]. Crit. Rev. Immunol. 16:1-11, 1996.
4. Berg, A., Halle, M.W. Baumstark, J. Keul, and H. Northoff. Spontaneously low LDL cholesterol and relation to exercise-induced stress. Lancet 347:405, 1996.
5. Beutler, B., and A. Cerami. The biology of cachectin/TNF - A primary mediator of the host response [Review]. Ann. Rev. Immunol. 7:625-655, 1989.
6. Beutler, B., Greenwald, J.D. Hulmes, M. Chang, Y.C. Pan, J. Mathison, R. Ulevitch, and A. Cerami. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-554, 1985.
7. Björntorp, P. Regional patterns of fat distribution. Ann. Intern. Med. 103:994-995, 1985.
8. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [Review]. Diabetes 46:3-10, 1997.
9. Boden, G., Chen, M. Mozzoli, and I. Ryan. Effect of fasting on serum leptin in normal human subjects. J. Clin. Endocrinol. Metab. 81:3419-3423, 1996.
10. Borkman, M., H. Storlien, D.A. Pan, A.B. Jenkins, D.J. Chisholm, and L.V. Campbell. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328:238-244, 1993.
11. Bouchard, C. Genetics of human obesity: Recent results from linkage studies. [Review]. J. Nutr. 127:1887S-1890S, 1997.
12. Campfield, L.A., J. Smith, Y. Guisez, R. Devos, and P. Burn. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995.
13. Caro, J.F., K. Sinha, J.W. Kolaczynski, P.L. Zhang, and R.V. Considine. Leptin: The tale of an obesity gene [Review]. Diabetes 45:1455-1462, 1996.
14. Caughey, G.E., Mantzioris, R.A. Gibson, L.G. Cleland, and M.J. James. The effect on human tumor necrosis factor-alpha and interleukin 1-beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 63:116-122, 1996.
15. Chehab, F.F. The reproductive side of leptin. Nature Med. 3:952-953, 1997.
16. Chehab, F.F., E. Lim, and R. Lu. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12:318-320, 1996.
17. Chen, H., Charlat, L.A. Tartaglia, E.A. Woolf, X. Weng, S.J. Ellis, N.D. Lakey, J. Culpepper, K.J. Moore, R.E. Breitbart, G.M. Duyk, R.I. Tepper, and J.P. Morgenstern. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495, 1996.
18. Considine, R.V., K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, et al. Serum inmunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295, 1996.
19. Dagogo-Jack, S., Fanelli, D. Paramore, J. Brothers, and M. Landt. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45:695-698, 1996.
20. Després, J.P., Lamarche, P. Mauriege, B. Cantin, G.R. Dagenais, S. Moorjani, and P.J. Lupien. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:952-957, 1996.
21. Dohm, G.L., B. Tapscott, W.J. Pories, D.J. Dabbs, E.G. Flickinger, D. Meelheim, T. Fushiki, S.M. Atkinson, C.W. Elton, and J.F. Caro. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82:486-494. 1998.
22. Drenth, J.P., H. Van Uum, M. Van Deuren, G.J. Pesman, J. Van der Ven-Jongekrijg, and J.W. Van der Meer. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J. Appl. Physiol. 79:1497-1503, 1995.
23. Feingold, K.R., and C. Grunfeld. Role of cytokines in inducing hyperlipidemia [Review]. Diabetes 41(Suppl 2): 97-101, 1992.
24. Feinstein, R., Kanety, M.Z. Papa, B. Lunenfeld, and A. Karasik. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268:26055-26058, 1993.
25. Fernandez-Real, J.M., Gutierrez, W. Ricart, R. Casamitjana, M. Fernandez-Castaner, J. Vendrell, C. Richart, and J. Soler. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468-1472, 1997.
26. Frederich, R.C., Hamann, S. Anderson, B. Lollmann, B.B. Lowell, and J.S. Flier. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Med. 1:1311-1314, 1995,
27. Garvey, W.T., P, Huecksteadt, S. Matthaei, and J.M. Olefsky. Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J. Clin. Invest. 81:1528-1536, 1988.
28. Grunfeld, C., and K.R. Feingold. The metabolic effects of tumor necrosis factor and other cytokines [Review]. Biotherapy 3:143-158, 1991,
29. Grunfeld, C., Zhao, J. Fuller, A. Pollack, A. Moser, J. Friedman, and K.R. Feingold. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97:2152-2157, 1996.
30. Halaas, J.L., S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L. Lallone, S.K. Burley, and J.M. Friedman. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995.
31. Hamilton, B.S., Paglia, A.Y. Kwan, and M. Deitel. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med. 1:953-956, 1995.
32. Hamsten, A., Walldius, A. Szamosi, M. Blombaeck, V. DeFaire, G. Dahlen, C. Landou, and B. Wiman. Plasminogen activator inhibitor in plasma: Risk for recurrent myocardial infarction. Lancet 3-8, 1987.
33. Hamsten, A., Wiman, U. De Faire, and M. Blombäck. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313:1557-1563, 1985.
34. Haring, H., and B. Obermaier-Kusser. Insulin receptor kinase defects in insulin-resistant tissues and their role in the pathogenesis of NIDDM [Review]. Diabetes Metab. Rev. 5:431-441, 1989,
35. Heinrich, J., Balleisen, H. Schulte, G. Assmann, and J. van de Loo. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler. Thromb. 14:54-59, 1994.
36. Helmrich, S.P., R. Ragland, R.W. Leung, and R.S. Paffenbarger, Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 325:147-152, 1991.
37. Hickey, M.S., A. Houmard, R.V. Considine, G.L. Tyndall, J.B. Midgette, K.E. Gavigan, M.L. Weidner, M.R. McCammon, R.G. Israel, and J.F. Caro. Gender-dependent effects of exercise training on serum leptin levels in humans. Am. J. Physiol. 35:E562-E566, 1997.
38. Hirsch, J., L. Leibel, and S.C. Chua. A clinical perspective on peptides and food intake [Review]. Am. J. Clin. Nutr. 55:296S-298S, 1992.
39. Hofmann, C., Lorenz, S.S. Braithwaite, J.R. Colea, B.J. Palazuk, G.S. Hotamisligil, and B.M. Spiegelman. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinol. 134:264-270, 1994.
40. Hotamisligil, G.S., Arner, R.L. Atkinson, and B.M. Spiegelman. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455, 1997.
41. Hotamisligil, G.S., Amer, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95:2409-2415, 1995.
42. Hotamisligil, G.S., Budavari, D. Murray, and B.M. Spiegelman. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 94:1543-1549, 1994.
43. Hotamisligil, G.S., S. Johnson, R.J. Distel, R. Ellis, V.E. Papaioannou, and B.M. Spiegelman. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379, 1996.
44. Hotamisligil, G.S., L. Murray, L.N. Choy, and B.M. Spiegelman. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91:4854-4858, 1994.
45. Hotamisligil, G.S., Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271:665-668, 1996.
46. Hotamisligil, G.S., S. Shargill, and B.M. Spiegelman. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91, 1993.
47. Hotamisligil, G.S., and B.M. Spiegelman. Tumor necrosis factor alpha: A key component of the obesity-diabetes link [Review]. Diabetes 43:1271-1278, 1994.
48. Hou, J., Baichwal, and Z. Cao. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 91:11641-11645, 1994.
49. Juhan-Vague, I., and M.C. Alessi. PAI-1, obesity, insulin resistance and risk of cardiovascular events [Review]. Thromb. Haemost. 78:656-660, 1997.
50. Kawakmi, M., H. Pekala, M.D. Lane, and A. Cerami. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc. Natl. Acad. Sci. USA 79:912-916, 1982.
51. Kern, P.A., Saghizadeh, J.M. Ong, R.J. Bosch, R. Deem, and R.B. Simsolo. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95:2111-2119, 1995.
52. Kishimoto, T., Taga, and S. Akira. Cytokine signal transduction [Review]. Cell 76:253-262, 1994.
53. Kohrt, W.M., Landt, and S.J. Birge. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. J. Clin. Endocrinol. 81:3980-3985, 1996.
54. Kolaczynski, J.W., V. Considine, J. Ohannesian, C. Marco, I. Opentanova, M.R. Nyce, M. Myint, and J.F. Caro. Responses of leptin to short-term fasting and refeeding in humans: A link with ketogenesis but not ketones themselves. Diabetes 45:1511-1515, 1996.
55. Kolaczynski, J.W., R, Nyce, R.V. Considine, G. Boden, JJ. Nolan, R. Henry, S.R. Mudaliar, J. Olefsky, and J.F. Caro. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 45:699-701, 1996.
56. König, D., Berg, C. Weinstock, J. Keul, and H. Northoff. Essential fatty acids, immune function, and exercise. Exerc Immunol. Rev. 3:1-31, 1997.
57. Landt, M., M. Lawson, J.M. Helgeson, V.G. Davila-Roman, J.H. Ladenson, A.S. Jaffe, and R.C. Hickner. Prolonged exercise decreases serum leptin concentrations. Metab. 46:1109-1112, 1997.
58. Lee, G.H., Proenca, J.M. Montez, K.M. Carroll, J.G. Darvishzadeh, J.I. Lee, and J.M. Friedman. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996.
59. Levi, M., Ten Gate, K.A. Bauer, T. van der Poll, T.S. Edgington, H.R. Buller, S.J. van Deventer, C.F. Hack, J.W. Ten Gate, and R.D. Rosenberg. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest. 93:114-120. 1994.
60. Lonnqvist, F., Arner, L. Nordfors, and M. Schalling. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med. 1:950-953, 1995.
61. Loskutoff, D.J., and F. Samad. The adipocyte and hemostatic balance in obesity: Studies of PAI-1. Arterioscler. Thromb. Vasc. Biol. 18:1-6, 1998,
62. Lynch, J., P. Helmrich, T.A. Lakka, G.A. Kaplan, R.D. Cohen, R. Salonen, and J.T. Salonen. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch. Intern. Med. 156:1307-1314, 1996.
63. Mantzoros, C.S., Moschos, I. Avramopoulos, V. Kaklamani, A. Liolios, D.E. Doulgerakis, I. Griveas, N. Katsilambros, and J.S. Flier. Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J. Clin. Endocrin. Metab. 82:3408-3413, 1997.
64. Marcand, S., Gilson, and D. Shore. A protein-counting mechanism for telomere length regulation in yeast. Science 275:986-990, 1997.
65. Maseri, A. Inflammation, atherosclerosis, and ischemic events-Exploring the hidden side of the moon [Editorial; comment]. N. Engl. J. Med. 336:1014-1016, 1997.
66. Massignon, D., Lepape, J. Bienvenu, Y. Barbier, C. Boileau, and P. Coeur. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state Haemostasis 24:36-48, 1994.
67. McGill, J.B., J. Schneider, C.L. Arfken, C.L. Lucore, and B.E. Sobel. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109, 1994.
68. Moller, D.E., and J.S. Flier. Insulin resistance - Mechanisms, syndromes, and implications [Review]. N. Engl. J. Med. 325:938-948, 1991.
69. Morin, C.L., H. Eckel, T. Marcel, and M.J. Pagliassotti. High fat diets elevate adipose tissue-derived tumor necrosis factor-alpha activity. Endocrinol. 138:4665-4671, 1997.
70. Nieman, D.C. Immune response to heavy exertion [Review]. J. Appl. Physiol. 82:1385-1394, 1997.
71. Nolan, J.J., M. Olefsky, M.R. Nyce, R.V, Considine, and J.F. Caro. Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes 45:1276-1278, 1996.
72. Northoff, H., Enkel, and C. Weinstock. Exercise, injury, and immune function. Exerc. Immunol. Rev. 1:1-25, 1995.
73. Northoff, H., Weinstock, and A. Berg. The cytokine response to strenuous exercise [Review]. Int. J. Sports Med. 15(Suppl 3): 167-171, 1994.
74. Old, L.J. Tumor necrosis factor (TNF). Science 230:630-632, 1985.
75. Olefsky, J.M. Lilly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective [Review]. Diabetes 30:148-162, 1981.
76. Osnes, L.T., B. Foss, G.B. Joo, C. Okkenhaug, A.B. Westvik, R. Ovstebo, and P. Kierulf. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alpha (TNF-alpha) in human monocytes. Thromb. Haemost. 76:970-976, 1996.
77. Pekala, P.H., Kawakami, C.W. Angus, M.D. Lane, and A. Cerami. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc. Natl. Acad. Sci. USA 80:2743-2747, 1983.
78. Pelleymounter, M.A., J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995.
79. Pennica, D., E. Nedwin, J.S. Hayflick, P.H. Seeburg, R. Derynck, M.A. Palladino, W.J. Kohr, B.B. Aggarwal, and D.V. Goeddel. Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724-729, 1984.
80. Peraldi, P., S. Hotamisligil, W.A. Buurman, M.F. White, and B.M. Spiegeman. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271:13018-13022, 1996.
81. Perusse, L., Collier, J. Gagnon, A.S. Leon, D.C. Rao, J.S. Skinner, J.H. Wilmore, A. Nadeau, P.Z. Zimmet, and C. Bouchard. Acute and chronic effects of exercise on leptin levels in humans. J. Appl. Physiol. 83:5-10, 1997.
82. Racette, S.B., W. Coppack, M. Landt, and S. Klein. Leptin production during moderate intensity aerobic exercise. J. Clin. Endocrin. Metab. 82:2275-2277, 1997.
83. Reaven, G.M. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
84. Ridker, P.M., Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:973-979, 1997.
85. Rink, T.J. Genetics. In search of a satiety factor. Nature 372:406-407, 1994.
86. Rönnemaa, T., Koskenvuo, J. Mamiemi, T. Koivunen, A. Sajantila, A. Rissanen, M. Kaitsaari, C. Bouchard, and J. Kaprio. Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat. J. Clin. Endocrin. Metab. 82:383-387, 1997.
87. Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809, 1993.
88. Ryan, A.S., and D. Elahi. The effects of acute hyperglycemia and hyperinsulimmia on plasma leptin levels - Its relationships with body fat, visceral adiposity, and age in women. J. Clin. Endocrin. Metab. 81:4433-4438, 1996.
89. Samad, F., and D.J. Loskutoff. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol. Med. 2:568-582, 1996.
90. Samad, P., and D.J. Loskutoff. The fat mouse: A powerful genetic model to study elevated plasminogen activator inhibitor-1 in obesity/NIDDM [Review]. Thromb. Haemost. 78:652-655, 1997.
91. Samad, F., Yamamoto, and D.J. Loskutoff. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-a and lipopolysaccharide. J. Clin. Invest. 97:37-46, 1996,
92. Sarraf, P., C. Frederich, E.M. Turner, G. Ma, N.T. Jaskowiak, D.J. Rivet III, J.S. Flier, B.B. Lowell, D.L. Fraker, and H.R. Alexander. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J. Exp. Med. 185:171-175, 1997.
93. Sawdey, M.S., and D.J. Loskutoff. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J. Clin. Invest. 88:1346-1353, 1991.
94. Shackelford, R.E., B. Alford, Y. Xue, S.F. Thai, D.O. Adams, and S. Pizzo. Aspirin inhibits tumor necrosis factor-alpha gene expression in murine tissue macrophages. Mol. Pharmacol. 52:421-429, 1997.
95. Shephard, R.J., and P.N. Shek. Heavy exercise, nutrition and immune function - Is there a connection? [Review]. Int. J. Sports Med. 16:491-497, 1995.
96. Spiegelman, B.M., and J.S. Flier. Adipogenesis and obesity: Rounding out the big picture [Review]. Cell 87:377-389, 1996.
97. Spiegelman, B.M., and G.S. Hotamisligil. Through thick and thin: Wasting, obesity, and TNF alpha [Review]. Cell 73:625-627, 1993.
98. Sprengers, E.D., and C. Kluft. Plasminogen activator inhibitors [Review]. Blood 69: 381-387, 1987.
99. Stephens, J.M., Lee, and P.F. Pilch. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272:971-976, 1997.
100. Stephens, J.M., and P.H. Pekala. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 266:21839-21845, 1991.
101. Tartaglia, L.A., Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G.J. Richards, LA. Campfield, F.T. Clark, J. Deeds, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271, 1995.
102. Tartaglia, L.A., and D.V. Goeddel. Two TNF receptors [Review]. Immunol. Today 13:151-153, 1992.
103. Tartaglia, L.A., Rothe, Y.F. Hu, and D.V. Goeddel. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor [Review]. Cell 73:213-216, 1993.
104. Torti, F.M., Dieckmann, B. Beutler, A. Cerami, and G.M. Ringold. A macrophage factor inhibits adipocyte gene expression: An in vitro model of cachexia. Science 229:867-869, 1985.
105. Uysal, K.T., M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil. Protection from obesity-induced insulin resistance in mice lacking TNF-a function. Nature 389:610-614, 1997.
106. Vague, P., Juhan-Vague, V. Chabert, M.C. Alessi, and C. Atlan. Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metabolism 38:913-915, 1989.
107. Van der Poll, T., M. Jansen, K.J. Van Zee, M.B. Welborn III, I. de Jong, C.E. Hack, H. Loetscher, W. Lesslauer, S.F. Lowry, and L.L. Moldawer. Tumor necrosis factoralpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor. Blood 88:922-927, 1996.
108. Van der Poll, T., Levi, S.J. van Deventer, H. Ten Cate, B.L. Haagmans, B.J. Biemond, H.R. Buller, C.E. Hack, and J.W. Ten Cate. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 83:446-451, 1994.
109. Vassalli, J.D., P. Sappino, and D. Belin. The plasminogen activator/plasmin system [Review]. J. Clin. Invest. 88:1067-1072, 1991.
110. Vilcek, J., and T.H. Lee. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions [Review], J. Biol. Chem. 266:7313-7316, 1991.
111. Weijenberg, M.P., J. Feskens, and D. Kromhout. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler. Thromb. Vasc. Biol. 16:499-503, 1996.
112. Weinstock, G., Konig, R. Harnischmacher, J. Keul, A. Berg, and H. Northoff. Effect of exhaustive exercise stress on the cytokine response. Med. Sci. Sports Exerc. 29:345-354, 1997.
113. Wilson, T.W., A. Kaplan, J. Kauhanen, R.D. Cohen, M. Wu, R. Salonen, and J.T. Salonen. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. Am. J. Epidemiol. 137:292-300, 1993,
114. Zhang, Y., Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994.